title: Ethical considerations in REM sleep behavior disorder.
abstract: A patient diagnosed with REM behavior sleep disorder (RBD) has as much as a 65% risk of developing an α-synucleinopathy. Currently, it is not possible to predict whether an individual will develop a disease, or, if so, which disease.The neurologist treating the patient must consider (1) the difference between disclosing a diagnosis and disclosing the risk of a diagnosis; (2) whether to disclose this risk to patients; and (3) if deciding to disclose the risk, the appropriate timing of such a conversation.
authors: Austin Neurology and Sleep Associates, 711-E1West 38th St, Austin, TX 78705, USA. svertrees@austinneurosleep.com
authors: Stephanie
authors: S
authors: Vertrees
authors: Glen P
authors: GP
authors: Greenough
mesh_terms: D000368:Aged; D030881:Disclosure / Q000941:ethics*; D006801:Humans; D008297:Male; D019636:Neurodegenerative Diseases / Q000209:etiology*; D017286:Polysomnography; D020187:REM Sleep Behavior Disorder / Q000150:complications* / Q000175:diagnosis*